AKT1 and cancer: AKT, which is activated by PI3K or phosphatidylinositol-dependent kinase (PDK), exhibits dysregulated expression or activation in various cancers, including ovarian, lung, and pancreatic cancers, in the context of growth factors, inflammation, and DNA damage.